These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
144 related items for PubMed ID: 20526846
1. Evaluation of the V404I and V509M amino acid substitutions of ERG11 gene in Candida albicans isolates by pyrosequencing. Kim TH, Lee MK. Folia Microbiol (Praha); 2010 May; 55(3):301-4. PubMed ID: 20526846 [Abstract] [Full Text] [Related]
2. Rapid detection of ERG11 gene mutations in clinical Candida albicans isolates with reduced susceptibility to fluconazole by rolling circle amplification and DNA sequencing. Wang H, Kong F, Sorrell TC, Wang B, McNicholas P, Pantarat N, Ellis D, Xiao M, Widmer F, Chen SC. BMC Microbiol; 2009 Aug 14; 9():167. PubMed ID: 19682357 [Abstract] [Full Text] [Related]
3. Mutations and/or Overexpressions of ERG4 and ERG11 Genes in Clinical Azoles-Resistant Isolates of Candida albicans. Feng W, Yang J, Xi Z, Qiao Z, Lv Y, Wang Y, Ma Y, Wang Y, Cen W. Microb Drug Resist; 2017 Jul 14; 23(5):563-570. PubMed ID: 27976986 [Abstract] [Full Text] [Related]
4. Drug resistance genes and trailing growth in Candida albicans isolates. Lee MK, Williams LE, Warnock DW, Arthington-Skaggs BA. J Antimicrob Chemother; 2004 Feb 14; 53(2):217-24. PubMed ID: 14688046 [Abstract] [Full Text] [Related]
5. In vitro fluconazole susceptibility of 1,903 clinical isolates of Candida albicans and the identification of ERG11 mutations. Ying Y, Zhao Y, Hu X, Cai Z, Liu X, Jin G, Zhang J, Zhang J, Liu J, Huang X. Microb Drug Resist; 2013 Aug 14; 19(4):266-73. PubMed ID: 23484590 [Abstract] [Full Text] [Related]
6. Molecular mechanisms associated with Fluconazole resistance in clinical Candida albicans isolates from India. Mane A, Vidhate P, Kusro C, Waman V, Saxena V, Kulkarni-Kale U, Risbud A. Mycoses; 2016 Feb 14; 59(2):93-100. PubMed ID: 26648048 [Abstract] [Full Text] [Related]
10. An A643T mutation in the transcription factor Upc2p causes constitutive ERG11 upregulation and increased fluconazole resistance in Candida albicans. Heilmann CJ, Schneider S, Barker KS, Rogers PD, Morschhäuser J. Antimicrob Agents Chemother; 2010 Jan 14; 54(1):353-9. PubMed ID: 19884367 [Abstract] [Full Text] [Related]
11. Susceptibility of clinical isolates of Candida species to fluconazole and detection of Candida albicans ERG11 mutations. Xu Y, Chen L, Li C. J Antimicrob Chemother; 2008 Apr 14; 61(4):798-804. PubMed ID: 18218640 [Abstract] [Full Text] [Related]
13. Nucleotide substitutions in the Candida albicans ERG11 gene of azole-susceptible and azole-resistant clinical isolates. Strzelczyk JK, Slemp-Migiel A, Rother M, Gołąbek K, Wiczkowski A. Acta Biochim Pol; 2013 Apr 14; 60(4):547-52. PubMed ID: 24340302 [Abstract] [Full Text] [Related]
14. Detection of ERG11 Overexpression in Candida albicans isolates from environmental sources and clinical isolates treated with inhibitory and subinhibitory concentrations of fluconazole. Morais Vasconcelos Oliveira J, Conceição Oliver J, Latércia Tranches Dias A, Barbosa Padovan AC, Siqueira Caixeta E, Caixeta Franco Ariosa M. Mycoses; 2021 Feb 14; 64(2):220-227. PubMed ID: 33176021 [Abstract] [Full Text] [Related]
15. Gain-of-function mutations in UPC2 are a frequent cause of ERG11 upregulation in azole-resistant clinical isolates of Candida albicans. Flowers SA, Barker KS, Berkow EL, Toner G, Chadwick SG, Gygax SE, Morschhäuser J, Rogers PD. Eukaryot Cell; 2012 Oct 14; 11(10):1289-99. PubMed ID: 22923048 [Abstract] [Full Text] [Related]
16. ERG11 mutations and expression of resistance genes in fluconazole-resistant Candida albicans isolates. Xu Y, Sheng F, Zhao J, Chen L, Li C. Arch Microbiol; 2015 Nov 14; 197(9):1087-93. PubMed ID: 26349561 [Abstract] [Full Text] [Related]